CEPI partners with Bharat Biotech, others to develop variant-proof Covid vaccine

The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced the latest award under its $200m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.

Related Keywords

Australia ,India ,Sydney ,New South Wales ,Switzerland ,Bharat ,Richard Hatchett ,James Triccas ,Krishna Ella ,Mariaj Wurm ,Bharat Biotech International Ltd ,Sydney Institute For Infectious Diseases ,Coalition For Epidemic Preparedness Innovations ,University Of Sydney ,How Apple ,Epidemic Preparedness Innovations ,Bharat Biotech ,Managing Director ,Prof James Triccas ,Sydney Institute ,Infectious Diseases ,Coalition For Epidemic Preparedness Innovations Cepi ,Sars Cov 2 ,Vaccine ,